As an unusual interleukin that induces the production of antibacterial proteins and specific chemokines, IL-22 has been shown to ameliorate pancreatitis, hepatitis, inflammatory bowel disease, ulcerative colitis and diabetic wounds [30–32]. This evidence concerns the gene IL22 and pancreatitis.